Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01990209
12:33:chronic_disease,56:78:chronic_disease,,,213:234:chronic_disease,240:260:chronic_disease,262:280:chronic_disease,297:319:chronic_disease,335:352:chronic_disease,358:405:chronic_disease,,446:456:treatment
History of myocardial infarction, unstable symptomatic ischemic heart disease, ongoing arrhythmias > Grade 2 (National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE], Version 4.0), thromboembolic events (eg, deep vein thrombosis, pulmonary embolism, or symptomatic cerebrovascular events), or any other cardiac condition (eg, pericardial effusion restrictive cardiomyopathy) within 6 months prior to first dose of study drug
3
[ "History", "of", "myocardial", "infarction", ",", "unstable", "symptomatic", "ischemic", "heart", "disease", ",", "ongoing", "arrhythmias", ">", "Grade", "2", "(", "National", "Cancer", "Institute", "[", "NCI", "]", "Common", "Terminology", "Criteria", "for", "Adverse", "Events", "[", "CTCAE", "]", ",", "Version", "4.0", ")", ",", "thromboembolic", "events", "(", "eg", ",", "deep", "vein", "thrombosis", ",", "pulmonary", "embolism", ",", "or", "symptomatic", "cerebrovascular", "events", ")", ",", "or", "any", "other", "cardiac", "condition", "(", "eg", ",", "pericardial", "effusion", "restrictive", "cardiomyopathy", ")", "within", "6", "months", "prior", "to", "first", "dose", "of", "study", "drug" ]
[ 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02342782
31:49:treatment,59:63:cancer,137:174:cancer,179:183:cancer
First remission after initial first-line therapy (CR1) in PTCL patients, except for anaplastic lymphoma receptor tyrosine kinase (ALK)+ anaplastic large cell lymphoma (ALCL) and CTCL
3
[ "First", "remission", "after", "initial", "first-line", "therapy", "(", "CR1", ")", "in", "PTCL", "patients", ",", "except", "for", "anaplastic", "lymphoma", "receptor", "tyrosine", "kinase", "(", "ALK", ")", "+", "anaplastic", "large", "cell", "lymphoma", "(", "ALCL", ")", "and", "CTCL" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 3, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02108860
7:16:chronic_disease,22:56:chronic_disease,58:69:chronic_disease,85:96:chronic_disease
Known infection with human immunodeficiency virus (HIV), hepatitis C, or a positive hepatitis B surface antigen
3
[ "Known", "infection", "with", "human", "immunodeficiency", "virus", "(", "HIV", ")", ",", "hepatitis", "C", ",", "or", "a", "positive", "hepatitis", "B", "surface", "antigen" ]
[ 0, 2, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01684904
12:23:treatment,,
the use of transfusion or other intervention to achieve Hgb ≥ 8.0 is acceptable
3
[ "the", "use", "of", "transfusion", "or", "other", "intervention", "to", "achieve", "Hgb", "≥", "8.0", "is", "acceptable" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02091141
13:35:chronic_disease,,72:87:chronic_disease,,111:132:chronic_disease,137:161:chronic_disease,,207:216:treatment,218:237:chronic_disease,242:257:chronic_disease
Significant cardiovascular disease, such as New York Heart Association cardiac disease (Class II or greater), myocardial infarction, or cerebrovascular accident within 3 months prior to initiation of study treatment, unstable arrhythmia, or unstable angina
3
[ "Significant", "cardiovascular", "disease", ",", "such", "as", "New", "York", "Heart", "Association", "cardiac", "disease", "(", "Class", "II", "or", "greater", ")", ",", "myocardial", "infarction", ",", "or", "cerebrovascular", "accident", "within", "3", "months", "prior", "to", "initiation", "of", "study", "treatment", ",", "unstable", "arrhythmia", ",", "or", "unstable", "angina" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2, 2, 0, 0, 0, 0 ]
NCT00368355
35:64:chronic_disease,,
Patients with pre-existing severe restrictive pulmonary disease (FVC less than 40% of predicted)
3
[ "Patients", "with", "pre-existing", "severe", "restrictive", "pulmonary", "disease", "(", "FVC", "less", "than", "40", "%", "of", "predicted", ")" ]
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02430051
13:29:chronic_disease
Significant motor impairment
3
[ "Significant", "motor", "impairment" ]
[ 0, 2, 2 ]
NCT02513797
34:67:treatment,76:96:treatment,98:118:treatment,122:154:treatment
Documented presence of implanted congenital defect closure devices, (e.g., atrial septal defect, patent foramen ovale or ventricular septal defect device)
3
[ "Documented", "presence", "of", "implanted", "congenital", "defect", "closure", "devices", ",", "(", "e.g.", ",", "atrial", "septal", "defect", ",", "patent", "foramen", "ovale", "or", "ventricular", "septal", "defect", "device", ")" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 1, 0 ]
NCT02811679
32:45:chronic_disease,54:62:chronic_disease,64:71:chronic_disease,73:80:chronic_disease,81:88:chronic_disease,90:99:chronic_disease,101:122:chronic_disease,124:142:chronic_disease,144:166:chronic_disease,168:177:chronic_disease
History of or current relevant CNS pathology such as epilepsy, seizure, paresis,aphasia, apoplexia, severe brain injuries, cerebellar disease, organic brain syndrome, psychosis
3
[ "History", "of", "or", "current", "relevant", "CNS", "pathology", "such", "as", "epilepsy", ",", "seizure", ",", "paresis", ",", "aphasia", ",", "apoplexia", ",", "severe", "brain", "injuries", ",", "cerebellar", "disease", ",", "organic", "brain", "syndrome", ",", "psychosis" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 2 ]
NCT02344355
14:34:chronic_disease,77:93:chronic_disease,143:152:treatment,166:190:chronic_disease,192:216:chronic_disease,218:236:chronic_disease,241:260:chronic_disease
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection that would result in a hospital stay or delay of treatment, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements or impact patient safety
3
[ "Uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", "that", "would", "result", "in", "a", "hospital", "stay", "or", "delay", "of", "treatment", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements", "or", "impact", "patient", "safety" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02484404
23:32:treatment,23:47:treatment,69:114:cancer
Patients who have had treatment with docetaxel for the treatment of metastatic castrate-sensitive prostate cancer
3
[ "Patients", "who", "have", "had", "treatment", "with", "docetaxel", "for", "the", "treatment", "of", "metastatic", "castrate-sensitive", "prostate", "cancer" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT02460835
21:42:treatment
contraindication to contrast-enhanced MRI
3
[ "contraindication", "to", "contrast-enhanced", "MRI" ]
[ 0, 0, 1, 1 ]
NCT03104725
18:21:allergy_name
Known allergy to NAC
3
[ "Known", "allergy", "to", "NAC" ]
[ 0, 0, 0, 4 ]
NCT02166905
38:56:cancer,58:72:cancer,85:105:cancer,112:124:treatment,156:180:cancer
Eligible patients will be women with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma after chemotherapy with no evidence of disease or minimal residual disease for primary or recurrent disease; this may or may not be measurable; these patients would normally enter a period of observation after standard management
3
[ "Eligible", "patients", "will", "be", "women", "with", "epithelial", "ovarian", ",", "fallopian", "tube", ",", "or", "primary", "peritoneal", "carcinoma", "after", "chemotherapy", "with", "no", "evidence", "of", "disease", "or", "minimal", "residual", "disease", "for", "primary", "or", "recurrent", "disease", ";", "this", "may", "or", "may", "not", "be", "measurable", ";", "these", "patients", "would", "normally", "enter", "a", "period", "of", "observation", "after", "standard", "management" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 0, 0, 0, 3, 3, 0, 1, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02476786
7:10:chronic_disease,37:59:treatment,123:142:treatment
Known HIV-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with endocrine therapies
3
[ "Known", "HIV-positivity", "on", "combination", "antiretroviral", "therapy", "because", "of", "the", "potential", "for", "pharmacokinetic", "interactions", "with", "endocrine", "therapies" ]
[ 0, 2, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02159560
17:35:treatment,
Expected use of epidural analgesia for >24 hours
3
[ "Expected", "use", "of", "epidural", "analgesia", "for", ">", "24", "hours" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02433158
25:28:chronic_disease
Documented diagnosis of SCD
3
[ "Documented", "diagnosis", "of", "SCD" ]
[ 0, 0, 0, 2 ]
NCT03113695
1:14:treatment,
Major surgery within 4 weeks prior to the start of treatment
3
[ "Major", "surgery", "within", "4", "weeks", "prior", "to", "the", "start", "of", "treatment" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02442323
1:15:cancer
adenocarcinoma subtypes
3
[ "adenocarcinoma", "subtypes" ]
[ 3, 0 ]
NCT03042689
11:17:chronic_disease,
new-onset angina within 3 months before randomization
3
[ "new-onset", "angina", "within", "3", "months", "before", "randomization" ]
[ 0, 2, 0, 0, 0, 0, 0 ]
NCT02131389
4:9:chronic_disease,,
Is Obese: (Defined for this study as having a BMI>45)
3
[ "Is", "Obese", ":", "(", "Defined", "for", "this", "study", "as", "having", "a", "BMI", ">", "45", ")" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02326818
11:37:treatment
Receiving botulinum toxin injections under 85-N-0195
3
[ "Receiving", "botulinum", "toxin", "injections", "under", "85-N-0195" ]
[ 0, 1, 1, 1, 0, 0 ]
NCT02531295
31:45:chronic_disease
Screening TSH consistent with hypothyroidism
3
[ "Screening", "TSH", "consistent", "with", "hypothyroidism" ]
[ 0, 0, 0, 0, 2 ]
NCT02498951
68:88:cancer
Clinical evidence of extra-central nervous system (CNS) (systemic) non-Hodgkin lymphoma
3
[ "Clinical", "evidence", "of", "extra-central", "nervous", "system", "(", "CNS", ")", "(", "systemic", ")", "non-Hodgkin", "lymphoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT01720836
62:95:cancer
Subjects must have histologically or cytologically confirmed non-small cell lung cancer (NSCLC
3
[ "Subjects", "must", "have", "histologically", "or", "cytologically", "confirmed", "non-small", "cell", "lung", "cancer", "(", "NSCLC" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0 ]
NCT02047721
12:40:chronic_disease,42:59:chronic_disease,61:86:chronic_disease,98:113:chronic_disease,115:128:chronic_disease,130:145:chronic_disease
history of cardiovascular disease (CVD), diabetes mellitus, uncontrolled hypertension, untreated thyroid disease, renal disease, hepatic disease, or any other medical condition affecting weight or energy metabolism
3
[ "history", "of", "cardiovascular", "disease", "(", "CVD", ")", ",", "diabetes", "mellitus", ",", "uncontrolled", "hypertension", ",", "untreated", "thyroid", "disease", ",", "renal", "disease", ",", "hepatic", "disease", ",", "or", "any", "other", "medical", "condition", "affecting", "weight", "or", "energy", "metabolism" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02582827
98:126:treatment,165:198:treatment,200:245:treatment,250:273:treatment,
Transfusion of blood products [red blood cells (RBC), white blood cells (WBC) or whole blood] or Hematopoietic growth factors or other hematologic support, such as erythropoiesis-stimulating agents, granulocyte-colony stimulating factor (G-CSF), or platelet transfusion(s) within 14 days of screening
3
[ "Transfusion", "of", "blood", "products", "[", "red", "blood", "cells", "(", "RBC", ")", ",", "white", "blood", "cells", "(", "WBC", ")", "or", "whole", "blood", "]", "or", "Hematopoietic", "growth", "factors", "or", "other", "hematologic", "support", ",", "such", "as", "erythropoiesis-stimulating", "agents", ",", "granulocyte-colony", "stimulating", "factor", "(", "G-CSF", ")", ",", "or", "platelet", "transfusion", "(", "s", ")", "within", "14", "days", "of", "screening" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02430077
36:39:allergy_name
Hypersensitivity or intolerance to OCA or any components of its formulation
3
[ "Hypersensitivity", "or", "intolerance", "to", "OCA", "or", "any", "components", "of", "its", "formulation" ]
[ 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0 ]
NCT02798458
12:26:chronic_disease,28:50:chronic_disease,62:83:chronic_disease
History of diverticulitis, diverticular stricture, and other intestinal strictures
3
[ "History", "of", "diverticulitis", ",", "diverticular", "stricture", ",", "and", "other", "intestinal", "strictures" ]
[ 0, 0, 2, 0, 2, 2, 0, 0, 0, 2, 2 ]
NCT02152995
14:34:chronic_disease,77:93:chronic_disease,107:131:chronic_disease,142:157:chronic_disease,167:177:chronic_disease,182:201:chronic_disease
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
3
[ "Uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 2, 2, 0, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01941316
18:31:treatment,
Must have had no major surgery within 28 days prior to enrollment
3
[ "Must", "have", "had", "no", "major", "surgery", "within", "28", "days", "prior", "to", "enrollment" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01508390
23:53:cancer
Histologically proven adenocarcinoma of the prostate
3
[ "Histologically", "proven", "adenocarcinoma", "of", "the", "prostate" ]
[ 0, 0, 3, 3, 3, 3 ]
NCT02120222
1:27:chronic_disease
inflammatory bowel disease
3
[ "inflammatory", "bowel", "disease" ]
[ 2, 2, 2 ]
NCT02577549
120:129:chronic_disease,131:146:chronic_disease,155:178:chronic_disease
Significant co-morbid disease that would threaten safety or impair ability to participate in interventions or testing (Blindness; Type 1 diabetes; Severe coronary artery disease)
3
[ "Significant", "co-morbid", "disease", "that", "would", "threaten", "safety", "or", "impair", "ability", "to", "participate", "in", "interventions", "or", "testing", "(", "Blindness", ";", "Type", "1", "diabetes", ";", "Severe", "coronary", "artery", "disease", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 2, 2, 2, 0 ]
NCT03043794
102:116:treatment
Subjects without placement of a biopsy clip at the diagnostic procedure who are unwilling to undergo clip placement
3
[ "Subjects", "without", "placement", "of", "a", "biopsy", "clip", "at", "the", "diagnostic", "procedure", "who", "are", "unwilling", "to", "undergo", "clip", "placement" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01616108
8:21:chronic_disease
Active eye infection
3
[ "Active", "eye", "infection" ]
[ 0, 2, 2 ]
NCT02531880
21:56:chronic_disease
Personal history of Parkinson s Disease or Parkinsonism or presence of this disease in a 1st degree relative
3
[ "Personal", "history", "of", "Parkinson", "s", "Disease", "or", "Parkinsonism", "or", "presence", "of", "this", "disease", "in", "a", "1st", "degree", "relative" ]
[ 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01547429
84:92:chronic_disease,94:108:treatment,117:129:chronic_disease,131:146:chronic_disease,170:184:chronic_disease
Abnormality of the iris or ocular structure which would preclude fixation, such as aniridia, hemiiridectomy, severe iris atrophy, rubeosis iridis, or other compromising iris pathology
3
[ "Abnormality", "of", "the", "iris", "or", "ocular", "structure", "which", "would", "preclude", "fixation", ",", "such", "as", "aniridia", ",", "hemiiridectomy", ",", "severe", "iris", "atrophy", ",", "rubeosis", "iridis", ",", "or", "other", "compromising", "iris", "pathology" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02496611
1:27:treatment
Previous bariatric surgery
3
[ "Previous", "bariatric", "surgery" ]
[ 1, 1, 1 ]
NCT03105362
20:34:treatment,
Patients receiving IV antibiotics within the previous 72h
3
[ "Patients", "receiving", "IV", "antibiotics", "within", "the", "previous", "72h" ]
[ 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02968602
,22:31:treatment,35:57:treatment,,96:109:treatment,111:126:treatment,128:144:treatment,146:169:treatment
Less than two months treatment of adjunctive medications AND less than one month on same dose: beta blockers, antidepressants, mood stabilizers, antianxiety medications
3
[ "Less", "than", "two", "months", "treatment", "of", "adjunctive", "medications", "AND", "less", "than", "one", "month", "on", "same", "dose", ":", "beta", "blockers", ",", "antidepressants", ",", "mood", "stabilizers", ",", "antianxiety", "medications" ]
[ 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 1, 1 ]
NCT02665338
12:22:chronic_disease
History of autoimmune
3
[ "History", "of", "autoimmune" ]
[ 0, 0, 2 ]
NCT03104699
48:74:cancer
Subjects must have recurrent, unresectable, or metastatic cervical cancer
3
[ "Subjects", "must", "have", "recurrent", ",", "unresectable", ",", "or", "metastatic", "cervical", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3 ]
NCT01697865
10:28:chronic_disease
Previous shoulder infection
3
[ "Previous", "shoulder", "infection" ]
[ 0, 2, 2 ]
NCT02250157
31:42:treatment,60:69:treatment,79:89:cancer
Are currently receiving other medications intended for the treatment of their malignancy
3
[ "Are", "currently", "receiving", "other", "medications", "intended", "for", "the", "treatment", "of", "their", "malignancy" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 3 ]
NCT01942018
1:33:treatment
Prior esophageal Botox injection
3
[ "Prior", "esophageal", "Botox", "injection" ]
[ 1, 1, 1, 1 ]
NCT02549833
41:49:treatment,74:93:treatment,113:128:cancer
must show supratentorial, non-enhancing T2-FLAIR lesions that need to be surgically resected and are likely WHO grade II glioma
3
[ "must", "show", "supratentorial", ",", "non-enhancing", "T2-FLAIR", "lesions", "that", "need", "to", "be", "surgically", "resected", "and", "are", "likely", "WHO", "grade", "II", "glioma" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 3, 3, 3 ]
NCT02189889
32:40:allergy_name
have known hypersensitivity to Feraheme or any of its components
3
[ "have", "known", "hypersensitivity", "to", "Feraheme", "or", "any", "of", "its", "components" ]
[ 0, 0, 0, 0, 4, 0, 0, 0, 0, 0 ]
NCT03122912
1:7:treatment,
Lovaza™ (prescription fish oil) and not willing to go off Lovaza for 3 weeks prior to enrollment to end of study
3
[ "Lovaza™", "(", "prescription", "fish", "oil", ")", "and", "not", "willing", "to", "go", "off", "Lovaza", "for", "3", "weeks", "prior", "to", "enrollment", "to", "end", "of", "study" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02519322
52:71:allergy_name
History of severe hypersensitivity reaction to any monoclonal antibody
3
[ "History", "of", "severe", "hypersensitivity", "reaction", "to", "any", "monoclonal", "antibody" ]
[ 0, 0, 0, 0, 0, 0, 0, 4, 4 ]
NCT02271919
19:33:chronic_disease,40:47:chronic_disease,51:71:chronic_disease,,,122:135:chronic_disease,,
History of severe kidney disease (e.g. chronic or acute kidney failure) with creatinine clearance below 30 and/or severe liver disease with liver tests over 4 times the upper normal level
3
[ "History", "of", "severe", "kidney", "disease", "(", "e.g", ".", "chronic", "or", "acute", "kidney", "failure", ")", "with", "creatinine", "clearance", "below", "30", "and/or", "severe", "liver", "disease", "with", "liver", "tests", "over", "4", "times", "the", "upper", "normal", "level" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562235
1:33:chronic_disease
Pulmonary veno-occlusive disease
3
[ "Pulmonary", "veno-occlusive", "disease" ]
[ 2, 2, 2 ]
NCT02503709
1:35:chronic_disease,31:34:chronic_disease,57:91:treatment,115:129:treatment,,
Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy known to interact with CYP isoenzymes are ineligible; in addition, HIV patients with CD4 count < 200 cells/uL are ineligible; appropriate studies will be undertaken in patients receiving combination antiretroviral therapy when indicated
3
[ "Human", "immunodeficiency", "virus", "(", "HIV", ")", "-positive", "patients", "on", "combination", "antiretroviral", "therapy", "known", "to", "interact", "with", "CYP", "isoenzymes", "are", "ineligible", ";", "in", "addition", ",", "HIV", "patients", "with", "CD4", "count", "<", "200", "cells/uL", "are", "ineligible", ";", "appropriate", "studies", "will", "be", "undertaken", "in", "patients", "receiving", "combination", "antiretroviral", "therapy", "when", "indicated" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03011567
29:44:treatment,80:99:treatment,103:125:chronic_disease
Use of therapeutic doses of anticoagulation (low dose anticoagulation used for routine prophylaxis of venous thromboembolism is acceptable)
3
[ "Use", "of", "therapeutic", "doses", "of", "anticoagulation", "(", "low", "dose", "anticoagulation", "used", "for", "routine", "prophylaxis", "of", "venous", "thromboembolism", "is", "acceptable", ")" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 2, 2, 0, 0, 0 ]
NCT02544880
14:25:chronic_disease
Uncontrolled arrhythmias
3
[ "Uncontrolled", "arrhythmias" ]
[ 0, 2 ]
NCT01620216
11:38:chronic_disease
Diagnosed congenital long QT syndrome
3
[ "Diagnosed", "congenital", "long", "QT", "syndrome" ]
[ 0, 2, 2, 2, 2 ]
NCT03013543
1:37:chronic_disease
LEPR Heterozygous Deficiency Obesity
3
[ "LEPR", "Heterozygous", "Deficiency", "Obesity" ]
[ 2, 2, 2, 2 ]
NCT02050113
4:12:chronic_disease,16:31:chronic_disease,62:90:chronic_disease
No systemic or local infection that may increase the risk of endovascular graft infection
3
[ "No", "systemic", "or", "local", "infection", "that", "may", "increase", "the", "risk", "of", "endovascular", "graft", "infection" ]
[ 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02444689
15:20:chronic_disease
Overweight or Obese
3
[ "Overweight", "or", "Obese" ]
[ 0, 0, 2 ]
NCT02542202
35:62:treatment,66:94:treatment,102:119:treatment
Patients may not be receiving any systemic anti-cancer agents or other investigational agents during radiation therapy
3
[ "Patients", "may", "not", "be", "receiving", "any", "systemic", "anti-cancer", "agents", "or", "other", "investigational", "agents", "during", "radiation", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 0, 1, 1 ]
NCT02568267
7:24:chronic_disease
Known active infections
3
[ "Known", "active", "infections" ]
[ 0, 2, 2 ]
NCT02498613
22:29:chronic_disease,31:54:chronic_disease,59:87:chronic_disease,
History of abdominal fistula, intra-abdominal abscess, or gastrointestinal perforation within the 3 months prior to enrollment
3
[ "History", "of", "abdominal", "fistula", ",", "intra-abdominal", "abscess", ",", "or", "gastrointestinal", "perforation", "within", "the", "3", "months", "prior", "to", "enrollment" ]
[ 0, 0, 0, 2, 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT03125902
5:8:chronic_disease,
The HBV DNA test will be performed only for patients who have a positive HBcAb test
3
[ "The", "HBV", "DNA", "test", "will", "be", "performed", "only", "for", "patients", "who", "have", "a", "positive", "HBcAb", "test" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02418195
23:40:treatment
capable of undergoing ketamine infusion
3
[ "capable", "of", "undergoing", "ketamine", "infusion" ]
[ 0, 0, 0, 1, 1 ]
NCT02236013
,,124:134:treatment
Female subject must not donate ova starting at Screening and throughout the study period, and for 180 days after the final study drug administration
3
[ "Female", "subject", "must", "not", "donate", "ova", "starting", "at", "Screening", "and", "throughout", "the", "study", "period", ",", "and", "for", "180", "days", "after", "the", "final", "study", "drug", "administration" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02642939
27:40:treatment,
Patients who have had any major surgery within 4 weeks prior to day 1 of cycle 1
3
[ "Patients", "who", "have", "had", "any", "major", "surgery", "within", "4", "weeks", "prior", "to", "day", "1", "of", "cycle", "1" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181516
1:20:treatment
Keflex (cephalexin)
3
[ "Keflex", "(", "cephalexin", ")" ]
[ 1, 1, 0, 0 ]
NCT01620216
1:26:chronic_disease
Uncontrolled hypertension
3
[ "Uncontrolled", "hypertension" ]
[ 2, 2 ]
NCT02943408
17:53:chronic_disease
Other Specified Trauma and Stressor-Related Disorder (309.89)
3
[ "Other", "Specified", "Trauma", "and", "Stressor-Related", "Disorder", "(", "309.89", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0 ]
NCT02400255
,60:67:treatment,,,108:129:treatment,,,165:185:treatment,
Adequate engraftment within 7 days prior to starting study therapy: ANC ≥ 1.0 x 109/L without daily use of myeloid growth factor; and platelet ≥ 25 x 109/L without platelet transfusion within 1 week
3
[ "Adequate", "engraftment", "within", "7", "days", "prior", "to", "starting", "study", "therapy", ":", "ANC", "≥", "1.0", "x", "109/L", "without", "daily", "use", "of", "myeloid", "growth", "factor", ";", "and", "platelet", "≥", "25", "x", "109/L", "without", "platelet", "transfusion", "within", "1", "week" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01969643
1:22:cancer
Malignant CNS disease that has not been definitively treated
3
[ "Malignant", "CNS", "disease", "that", "has", "not", "been", "definitively", "treated" ]
[ 3, 3, 3, 0, 0, 0, 0, 0, 0 ]
NCT01850758
23:26:treatment
Contraindications for MRI
3
[ "Contraindications", "for", "MRI" ]
[ 0, 0, 1 ]
NCT02518594
12:18:chronic_disease
History of herpes
3
[ "History", "of", "herpes" ]
[ 0, 0, 2 ]
NCT03135522
1:25:chronic_disease
Congestive heart failure
3
[ "Congestive", "heart", "failure" ]
[ 2, 2, 2 ]
NCT02724540
1:12:cancer,,
liver tumor burden less than or equal to 70% of the total liver volume by visual estimate
3
[ "liver", "tumor", "burden", "less", "than", "or", "equal", "to", "70", "%", "of", "the", "total", "liver", "volume", "by", "visual", "estimate" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02215096
13:48:treatment,59:79:treatment,,153:162:treatment
Presence of hepatitis B surface antigen (HBsAg), positive hepatitis C antibody test result at screening or within 3 months prior to first dose of study treatment
3
[ "Presence", "of", "hepatitis", "B", "surface", "antigen", "(", "HBsAg", ")", ",", "positive", "hepatitis", "C", "antibody", "test", "result", "at", "screening", "or", "within", "3", "months", "prior", "to", "first", "dose", "of", "study", "treatment" ]
[ 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01595529
1:11:treatment
Cephalexin
3
[ "Cephalexin" ]
[ 1 ]
NCT02759120
1:30:treatment,36:48:treatment,50:63:treatment,65:81:treatment,86:98:treatment
Concomitant immunosuppression with azathioprine, mycophenolate, cyclophosphamide, or cyclosporine
3
[ "Concomitant", "immunosuppression", "with", "azathioprine", ",", "mycophenolate", ",", "cyclophosphamide", ",", "or", "cyclosporine" ]
[ 1, 1, 0, 1, 0, 1, 0, 1, 0, 0, 1 ]
NCT01604512
22:29:allergy_name
allergic reaction to Gd-DTPA
3
[ "allergic", "reaction", "to", "Gd-DTPA" ]
[ 0, 0, 0, 4 ]
NCT01532687
48:79:cancer,102:119:cancer,145:159:cancer
subjects with a history of completely resected non-melanomatous skin carcinoma, successfully treated in situ carcinoma, or successfully treated bladder cancer are eligible
3
[ "subjects", "with", "a", "history", "of", "completely", "resected", "non-melanomatous", "skin", "carcinoma", ",", "successfully", "treated", "in", "situ", "carcinoma", ",", "or", "successfully", "treated", "bladder", "cancer", "are", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 3, 3, 0, 0 ]
NCT01366612
14:20:chronic_disease
uncontrolled angina
3
[ "uncontrolled", "angina" ]
[ 0, 2 ]
NCT02637947
19:40:chronic_disease
subject has had a myocardial infarction
3
[ "subject", "has", "had", "a", "myocardial", "infarction" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT02163317
,,49:64:treatment
PSA should not be obtained within 10 days after prostate biopsy
3
[ "PSA", "should", "not", "be", "obtained", "within", "10", "days", "after", "prostate", "biopsy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03123068
1:27:treatment,,60:72:treatment,76:88:treatment
Immune-suppressant therapy within the last 2 months (e.g., azathioprine or cyclosporine)
3
[ "Immune-suppressant", "therapy", "within", "the", "last", "2", "months", "(", "e.g.", ",", "azathioprine", "or", "cyclosporine", ")" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0 ]
NCT02819635
14:32:chronic_disease,
Diagnosis of ulcerative colitis for 90 days or greater prior to Baseline, confirmed by colonoscopy during the Screening Period
3
[ "Diagnosis", "of", "ulcerative", "colitis", "for", "90", "days", "or", "greater", "prior", "to", "Baseline", ",", "confirmed", "by", "colonoscopy", "during", "the", "Screening", "Period" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02031250
1:3:cancer,7:19:cancer,23:44:cancer
T3 or T4 laryngeal or hypopharyngeal cancer that is locally advanced
3
[ "T3", "or", "T4", "laryngeal", "or", "hypopharyngeal", "cancer", "that", "is", "locally", "advanced" ]
[ 3, 0, 3, 3, 0, 3, 3, 0, 0, 0, 0 ]
NCT02977299
,33:67:treatment,
received at least one dose of a monoamine oxidase inhibitor (MAOI) four weeks or less prior
3
[ "received", "at", "least", "one", "dose", "of", "a", "monoamine", "oxidase", "inhibitor", "(", "MAOI", ")", "four", "weeks", "or", "less", "prior" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02784535
20:38:chronic_disease
History of serious neurologic disease
3
[ "History", "of", "serious", "neurologic", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02589340
1:33:chronic_disease
Significant cognitive impairment
3
[ "Significant", "cognitive", "impairment" ]
[ 2, 2, 2 ]
NCT01622868
,21:34:cancer,51:71:treatment,75:98:treatment,102:142:treatment,146:181:treatment,
HER2-overexpressing breast cancer (3+ staining by immunohistochemistry or HER2 gene amplification by fluorescent in situ hybridization [FISH] or silver in situ hybridization [SISH] >= 2.0)
3
[ "HER2-overexpressing", "breast", "cancer", "(", "3+", "staining", "by", "immunohistochemistry", "or", "HER2", "gene", "amplification", "by", "fluorescent", "in", "situ", "hybridization", "[", "FISH", "]", "or", "silver", "in", "situ", "hybridization", "[", "SISH", "]", ">", "=", "2.0", ")" ]
[ 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02857218
15:34:chronic_disease
Patients with renal insufficiency
3
[ "Patients", "with", "renal", "insufficiency" ]
[ 0, 0, 2, 2 ]
NCT02259504
30:36:treatment,38:48:treatment,52:65:treatment
Use of other modified coils (Matrix, HydroCoil® or fibered coils)
3
[ "Use", "of", "other", "modified", "coils", "(", "Matrix", ",", "HydroCoil®", "or", "fibered", "coils", ")" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02098161
,,,,180:219:treatment
Pregnant or breast feeding (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive beta-human chorionic gonadotropin (HCG) laboratory test
3
[ "Pregnant", "or", "breast", "feeding", "(", "lactating", ")", "women", ",", "where", "pregnancy", "is", "defined", "as", "the", "state", "of", "a", "female", "after", "conception", "and", "until", "the", "termination", "of", "gestation", ",", "confirmed", "by", "a", "positive", "beta-human", "chorionic", "gonadotropin", "(", "HCG", ")", "laboratory", "test" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0 ]
NCT00630565
1:29:cancer
Acute myeloid leukemia (AML)
3
[ "Acute", "myeloid", "leukemia", "(", "AML", ")" ]
[ 3, 3, 3, 3, 0, 0 ]
NCT02943408
1:15:chronic_disease
panic disorder (300.01)
3
[ "panic", "disorder", "(", "300.01", ")" ]
[ 2, 2, 0, 0, 0 ]
NCT02593526
24:43:treatment,
Intention to change to peritoneal dialysis, or home HD in the next 6 months
3
[ "Intention", "to", "change", "to", "peritoneal", "dialysis", ",", "or", "home", "HD", "in", "the", "next", "6", "months" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01625234
20:68:treatment,70:93:treatment,99:120:treatment
Patients receiving CYP3A substrates with narrow therapeutic indices, strong CYP3A inhibitors, and strong CYP3A inducers
3
[ "Patients", "receiving", "CYP3A", "substrates", "with", "narrow", "therapeutic", "indices", ",", "strong", "CYP3A", "inhibitors", ",", "and", "strong", "CYP3A", "inducers" ]
[ 0, 0, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02058095
22:35:chronic_disease,,,,,
Patients with severe liver disease (AST > 3x normal, alkaline phosphatase or bilirubin > 2x normal)
3
[ "Patients", "with", "severe", "liver", "disease", "(", "AST", ">", "3x", "normal", ",", "alkaline", "phosphatase", "or", "bilirubin", ">", "2x", "normal", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02131467
1:10:chronic_disease
hepatitis
3
[ "hepatitis" ]
[ 2 ]
NCT02500381
25:28:chronic_disease
Genotypically confirmed DMD, with genetic deletion amenable to exon 45 or exon 53 skipping
3
[ "Genotypically", "confirmed", "DMD", ",", "with", "genetic", "deletion", "amenable", "to", "exon", "45", "or", "exon", "53", "skipping" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]